These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


124 related items for PubMed ID: 3282354

  • 21. The use of OKT3 for stubborn heart allograft rejection: an advance in clinical immunotherapy?
    Sweeney MS, Sinnott JT, Cullison JP, Weinstein SS.
    J Heart Transplant; 1987; 6(6):324-8. PubMed ID: 3320302
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. OKT3 monoclonal antibody given for ten versus fourteen days as immunosuppressive prophylaxis in heart transplantation.
    Hegewald MG, O'Connell JB, Renlund DG, Lee HR, Burton NA, Karwande SV, Jones KW, Lassetter JE, Bristow MR.
    J Heart Transplant; 1989; 8(4):303-9; discussion 309-10. PubMed ID: 2504897
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Successful reversal of acute cardiac allograft rejection with OKT*3 monoclonal antibody.
    Costanzo-Nordin MR, Silver MA, O'Connell JB, Pifarre R, Grady KL, Winters GL, Murdock DK, Sullivan HJ, Grieco JG, Scanlon PJ.
    Circulation; 1987 Nov; 76(5 Pt 2):V71-80. PubMed ID: 3311459
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. OKT3 monoclonal antibody in heart transplantation.
    Bristow MR, Gilbert EM, O'Connell JB, Renlund DG, Watson FS, Hammond E, Lee RG, Menlove R.
    Am J Kidney Dis; 1988 Feb; 11(2):135-40. PubMed ID: 3277404
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Evolving use of OKT3 monoclonal antibody for treatment of renal allograft rejection.
    Thistlethwaite JR, Cosimi AB, Delmonico FL, Rubin RH, Talkoff-Rubin N, Nelson PW, Fang L, Russell PS.
    Transplantation; 1984 Dec; 38(6):695-701. PubMed ID: 6390834
    [Abstract] [Full Text] [Related]

  • 37. A randomized clinical trial of OKT3 monoclonal antibody for acute rejection of cadaveric renal transplants.
    Ortho Multicenter Transplant Study Group.
    N Engl J Med; 1985 Aug 08; 313(6):337-42. PubMed ID: 2861567
    [Abstract] [Full Text] [Related]

  • 38. OKT3: First-dose safety and success.
    Cosimi AB.
    Nephron; 1987 Aug 08; 46 Suppl 1():12-8. PubMed ID: 3306421
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 7.